Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Tibial Osteotomies
NCT04785651Terminated
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Feb 2021
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in osteoarthritis (OA) (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Perioperative blood loss (haemoglobin balance) at 1 day. Started Feb 2021; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04785651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04785651.